The orthobiologics market in Asia is estimated to grow to around $703.9 million by 2018 - New Report by MicroMarket Monitor

Share Article

The Asian orthobiologics report defines and segments the concerned market in Asia with analysis and forecast of revenue. http://www.micromarketmonitor.com/market/asia-orthobiologics-7943449547.html

MicroMarket Monitor

MicroMarket Monitor

Key Players in the Asian orthobiologics market are Stryker, Zimmer, DePuy Synthes, Medtronic, Smith and Nephew

The orthobiologics market in Asia is estimated to grow to around $703.9 million by 2018, at a developing CAGR of 5.2% from 2013 to 2018.

Browse through the TOC of the Asian orthobiologics market, to get an idea of the in-depth analysis provided. This also provides a glimpse of the segmentation of orthobiologics market in the same region, and is supported by various tables and figures.

http://www.micromarketmonitor.com/market/asia-orthobiologics-7943449547.html

The major factors driving the growth of the Asian orthopedic devices market is the increase in the region’s middle class population, having higher disposable income and spending capabilities for orthopedic conditions. Besides, the change in the mindset of people with growing medical awareness has resulted into people wishing to have better and active lifestyle, by making use of less invasive procedures that have several benefits such as less pain, less scarring, shorter hospital stay and higher accuracy.

Speak to Analyst @

http://www.micromarketmonitor.com/contact/7943449547-speak_to_analyst.html

The main consumers of the orthobiologics market who undergo several surgeries such as total hip or knee replacement and spinal fusion is the ageing population. Besides, the old population, the cases of road accidents and rise in the number of sports injuries has also accelerated the growth in this market. In Asia, the devices are advanced and are less expensive. The major markets in this region include China, Japan, and India. Japan is the largest market for orthopedic products and orthobiologics market, and in 2014, it accounts for 40% of the Asian market.

Early buyers will receive 10% customization on this report.

http://www.micromarketmonitor.com/contact/7943449547-request_for_customization.html

This market is segmented and forecast on the basis of various types of products, namely, bone allograft, bone graft substitutes, bone growth factors & spinal stimulation, stem cell therapy, and viscosupplementation. The market is further segmented and forecast on the basis of major countries, such as the Japan, China, and India. The market is also segmented and analyzed further on the basis of the end users.

This report also includes the market share, value chain analyses, and market metrics such as drivers, restraints and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key players in the market.

Related Reports:

North American Orthobiologics Market

Orthobiologics are substances that orthopedic surgeons use to help injuries heal more quickly. They are used to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in human body.

The North American Orthobiologics Market is mainly driven by innovation in implant technologies and shifting demand from mechanical to biological solutions. The report “North American Orthobiologics Market forecast, 2012-2018” analyzes the market of Orthobiologics industry by 6 product segments such as Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy and Visco-supplementation.

All of these segments experience a positive growth from 2012 with an increased demand for technological advances in bone graft materials. The markets have been witnessing the maximum growth because of demand for innovative products and Rising prevalence of chronic arthritis and rapidly aging world population.

http://www.micromarketmonitor.com/market/north-america-orthobiologics-9077664565.html

European Orthobiologics Market

Orthobiologics are substances that orthopedic surgeons use to help injuries heal more quickly. They are used to improve the healing of broken bones and injured muscles, tendons, and ligaments. These products are made from substances that are naturally found in human body.

The European Orthobiologics Market is mainly driven by innovation in implant technologies and shifting demand from mechanical to biological solutions. The report “European Orthobiologics Market forecast, 2012-2018” analyzes the market of Orthobiologics industry by 6 product segments such as Bone Allograft, Bone Graft Substitutes, Bone Growth Factors & Spinal Stimulation, Stem Cell Therapy and Visco-supplementation.

All of these segments experienced a positive growth from 2012 with an increased demand for technological advances in bone graft materials. The markets have been witnessing the maximum growth because of demand for innovative products and rising prevalence of chronic arthritis and rapidly aging world population.

http://www.micromarketmonitor.com/market/europe-orthobiologics-9908210168.html

About MicroMarket Monitor:

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Contact:
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales(at)micromarketmonitor(dot)com
Connect with us on LinkedIn at http://www.linkedin.com/company/micromarketmonitor.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Mr. Chandrasekhar K.
Micro Market Monitor
Like >
Visit website